United States · FDA National Drug Code directory
Kovaltry
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0026-3826_f4bed724-db3e-448e-8947-2f6a6913f1ee
- Product NDC
- 0026-3826
- Form
- KIT
- Composition / generic term
- Antihemophilic Factor (Recombinant)
- Labeler
- Bayer HealthCare LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20160317
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 BOX (0026-3826-50) * 5 mL in 1 VIAL, SINGLE-USE (0026-4826-99) * 5 mL in 1 SYRINGE (0026-0426-15) * 5 mL in 1 VIAL, SINGLE-USE (0026-4826-01) * 5 mL in 1 SYRINGE (0026-0426-05) · 0026-3826-50
- 1 KIT in 1 BOX (0026-3826-99) * 5 mL in 1 VIAL, SINGLE-USE (0026-4826-99) * 5 mL in 1 SYRINGE (0026-0426-15) * 5 mL in 1 VIAL, SINGLE-USE (0026-4826-01) * 5 mL in 1 SYRINGE (0026-0426-05) · 0026-3826-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →